this drug , currently used in inflammatory bowel disease treatment , is reductively cleaved by anaerobic bacteria in the lower bowel to 5-aminosalicylic acid ( 5-asa ) and sulfapyridine ( sp ) .
C0021390
inflammatory
C0021853
bowel